Knowledge and Perspective of Healthcare Professionals About Female Genital Mutation (FMG-HCPROF)
February 4, 2022 updated by: Simone Ferrero, Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia
Knowledge and Perspective of Healthcare Professionals Related to Female Genital Mutation: a Regional Survey
Each year over three million girls are at risk of being subjected to female genital mutilation (FGM) in several African countries.
This regional survey aims to evaluate knowledge and perspective of healthcare professionals related to FGM.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The survey iscomposed of 4 different sections: the first section included questions about demographic data of participants; the second part evaluated responders' knowledge about FGM; the third section focused on participants' working experience with patients affected by FGM and personal attitude related to this topic.
Study Type
Observational
Enrollment (Actual)
450
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Genova, Italy, 16132
- IRCCS Ospedale Policlinico San Martino
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
healthcare professionals working in Genoa
Description
Inclusion Criteria:
- medical specialists
- general medical practicians
- medical residents
- midwives
- professional nurses
- medical students
- residence in Liguria (Italy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthcare professionals
Healthcare professionals (medical specialists and general practitioners, medical residents, midwives, professional nurses, medical students).
|
The survey is composed of 4 different sections: the first section included questions about demographic data of participants; the second part evaluated responders' knowledge about FGM; the third section focused on participants' working experience with patients affected by FGM and personal attitude related to this topic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean score related to knowledge about FGM
Time Frame: Baseline
|
10-point score (0:minimal knowledge; 10: extensive knowledge) related to the knowledge of responders about FGM
|
Baseline
|
|
Proportion of responders with active role in contrasting the procedures
Time Frame: Baseline
|
Evalution of the personale attitude of responders to the topic (active role in contrasting the procedures)
|
Baseline
|
|
Proportion of responders feeling confortable in treating patients affected
Time Frame: Baseline
|
Evalution of the personale attitude of responders to the topic (responders feeling confortable in treating patients affected)
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
July 31, 2021
Study Registration Dates
First Submitted
June 19, 2021
First Submitted That Met QC Criteria
June 19, 2021
First Posted (Actual)
June 23, 2021
Study Record Updates
Last Update Posted (Actual)
February 7, 2022
Last Update Submitted That Met QC Criteria
February 4, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- FMG-HEALTHCAREPROF-SURVEY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.